To order this 375+ page report, which features 180+ figures and 195+ tables, please visit https://www.rootsanalysis.com/reports/view_document/ophthalmic-drugs-cmo/294.html
The USD 1.7 billion financial opportunity (by 2030) within the ophthalmic drugs contract manufacturing market has been analyzed across the following segments:
§ Type of product
§ Ophthalmic API
§ Ophthalmic drug FDF
§ Type of FDF manufactured
§ Solid
§ Semi-solid
§ Liquid / suspension
§ Type of primary packaging
§ Ampoule / vial
§ Glass / plastic bottle
§ Ointment tube
§ Blister packing
§ Other forms
§ Scale of manufacturing
§ Clinical
§ Commercial
§ Company size
§ Small
§ Mid-sized
§ Large
§ Very large
§ Target disease indication
§ Age-related macular degeneration
§ Dry eye
§ Glaucoma
§ Other disease segments
§ Key geographical regions
§ North America (US, Canada and Mexico)
§ Europe (UK, Germany, France, Spain, Italy and rest of Europe)
§ Asia-Pacific (India, China, Japan, Australia and rest of Asia-Pacific)
§ Rest of the world
The Ophthalmic Drugs Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms (Ophthalmic Drops, Emulsions, Gels, Injections, Lotions, Ointments, Suspensions, and Tablets / Capsules), 2020-2030 report features the following companies, which we identified to be key players in this domain:
§ Akorn
§ Akums
§ Bal Pharma
§ Catalent
§ Cayman Chemical
§ Entod Pharmaceuticals
§ Farmigea
§ Glenmark Pharmaceuticals
§ Indiana Ophthalmics
§ Lomapharm
§ Medichem
§ Pillar5 Pharma
§ Recipharm
§ Salvat
§ Sterling Pharmaceutical Services
§ Sunways India
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Current Market Landscape
5. Company Competitiveness Analysis
6. Ophthalmic Drugs Contract Manufacturing in North America: Company Profiles
7. Ophthalmic Drugs Contract Manufacturing in Europe: Company Profiles
8. Ophthalmic Drugs Contract Manufacturing in Asia-Pacific: Company Profiles
9. Clinical Trial Analysis
10. Capacity Analysis
11. Demand Analysis
12. Market Forecast
13. Case Study: Comparison of Small Molecule and Large Molecule Ophthalmic Drugs / Therapies
14. SWOT Analysis
15. Survey Analysis
16. Executive Insights
17. Future Growth Opportunities
18. Appendix 1: List of Ophthalmic Medical Device Contract Manufacturers
19. Appendix 2: Tabulated Data
20. Appendix 3: List of Companies and Organizations
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/ophthalmic-drugs-cmo/294.html
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis
Medium - https://medium.com/@RootsAnalysis
Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/
